Sector Expert: Jim Letourneau

Big Picture Speculator

Image: Jim Letourneau

Jim Letourneau is the founder and editor of the Big Picture Speculator and is a geologist living in Calgary, Alberta. He is an early-stage investor in energy, metals, biotech and technology companies. He speaks at investment conferences across North America.



Recent Interviews

Fracking, Uranium and Solar, Oh My!: Growth and Innovation in 2013 (12/26/13)

A more profitable outcome often requires a new way of doing things. The Energy Report profiled some of the most innovative stories in the energy space in 2013. Our experts talked about everything from developments in hydraulic fracturing techniques to new ways of finding and processing natural resources. As we look forward to exciting new opportunities in 2014, let's revisit some stories our experts shared last year.

Adventures in the Biotech Trade with Jim Letourneau (8/15/13)

Jim Letourneau, publisher of Big Picture Speculator, shares tales of strange biotechnologies worth buying into—such as cures for high dental bills and dog breath—in this interview with The Life Sciences Report. Letourneau likes to invest in biotech firms because their stock values are less volatile than commodity-based companies, which are chained to uncontrollable price fluctuations. You are advised to hold onto your brain (quite literally), while Letourneau describes a few curious—and potentially profitable—biotech investment adventures.

Smart Fracking: Jim Letourneau on Enhanced Oil Recovery with Competitive Costs (8/8/13)

What's the difference between an oil well and a very expensive hole in the ground? Advanced hydraulic fracturing techniques, in many cases. That's why Big Picture Speculator Editor Jim Letourneau is following service companies that are helping producers get to the finish line on time and under budget. In this interview with The Energy Report, Letourneau discusses new ways to play the ever-evolving shale revolution.

Recent Quotes

"ONCY's Reolysin reovirus can inject into tumors to kill cancerous cells."

The Life Sciences Report Interview with Jim Letourneau (8/15/13)
more >

"VRS has an amazing, game-changing device that detects skin cancer with good accuracy."

The Life Sciences Report Interview with Jim Letourneau (8/15/13)
more >

"BTI's Transcend technology allows drugs to cross the blood-brain barrier, which is a big issue for treating brain disease."

The Life Sciences Report Interview with Jim Letourneau (8/15/13)
more >

"BSP has a big land position with a foot in the Wolfberry door."

The Energy Report Interview with Jim Letourneau (8/8/13)
more >

"ZEX has a big land package in California's San Joaquin Basin and has farmed some of it out."

The Energy Report Interview with Jim Letourneau (8/8/13)
more >

"I think everyone is expecting BSP's share value to grow."

The Energy Report Interview with Jim Letourneau (4/25/13)
more >

"URE just closed a $5.1M transaction that provides upfront cash in return for future uranium deliveries."

The Energy Report Interview with Jim Letourneau (4/25/13)
more >

"VRS' platform is very compelling."

The Life Sciences Report Interview with Jim Letourneau (1/17/13)
more >



Due to permission requirements, not all quotes are shown.